Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population

Allele and Genotype Frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese Populations

(2012) Liang Jin Zuo et al.   Genetic Testing and Molecular Biomarkers

CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects

(2012) Mark Y Chan et al.   PHARMACOGENOMICS

Association between cytochrome P450 2C19 polymorphism and clinical outcomes in Chinese patients with coronary artery disease

(2011) Mao Chen et al.   ATHEROSCLEROSIS

Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development

(2011) Kouichi Kurose et al.   Drug Metabolism and Pharmacokinetics

Distribution of CYP2C19*17 allele and genotypes in an Indian population

(2011) D. Anichavezhi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations

(2011) S.-J. Yin et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Polymorphism of human cytochrome P450 enzymes and its clinical impact

(2009) Shu-Feng Zhou et al.   DRUG METABOLISM REVIEWS

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

(2009) Q Zhou et al.   PHARMACOGENOMICS JOURNAL

Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism

(2008) László Kóbori et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China

(2008) Lingling Chen et al.   PHARMACOGENOMICS